Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults	AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease	Recruiting	Phase 1	2025-10-07		NCT06205056

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Duke University	446
Henry M. Jackson Foundation for the Advancement of Military Medicine	35
Janssen Vaccines & Prevention B.V.	1
Makerere University Walter Reed Project	1
National Institute of Allergy and Infectious Diseases (NIAID)	402
U.S. Army Medical Research and Development Command	21
Walter Reed Army Institute of Research (WRAIR)	16

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Makerere University Walter Reed Project (MUWRP)	Kampala	Uganda	1